Smad1 , Smad8 (AA 456-465), (pSer463), (pSer465) antibody
Quick Overview for Smad1 , Smad8 (AA 456-465), (pSer463), (pSer465) antibody (ABIN1177176)
Target
Reactivity
Host
Clonality
Application
Clone
-
-
Binding Specificity
- AA 456-465, pSer463, pSer465
-
Purification
- The monoclonal antibody was purified from tissue culture supernatant or ascites by affinity chromatography.
-
Immunogen
- Phosphorylated Human Smad1 aa 456-465 Peptide
-
Isotype
- IgG2a kappa
-
-
-
Protocol
- In human PBMC, overnight serum starvation was found to be necessary for detection of a BMP-6-induced increase in Smad1/8 phosphorylation. Serum starvation for 1 hour following PBMC isolation was not sufficient to reduce basal levels of Smad1 (pS463/pS465)/Smad8(pS465/pS467). Some donor variation was observed in the reduction of basal phosphorylation by overnight serum starvation.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.5 mg/mL
-
Buffer
- Aqueous buffered solution containing ≤0.09 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- Store undiluted at 4°C.
-
-
-
: "Smads and early developmental signaling by the TGFbeta superfamily." in: Genes & development, Vol. 12, Issue 16, pp. 2445-62, (1998) (PubMed).
: "Opposing BMP and EGF signalling pathways converge on the TGF-beta family mediator Smad1." in: Nature, Vol. 389, Issue 6651, pp. 618-22, (1997) (PubMed).
: "The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase." in: Genes & development, Vol. 11, Issue 8, pp. 984-95, (1997) (PubMed).
: "Bone morphogenetic proteins: multifunctional regulators of vertebrate development." in: Genes & development, Vol. 10, Issue 13, pp. 1580-94, (1996) (PubMed).
: "MADR1, a MAD-related protein that functions in BMP2 signaling pathways." in: Cell, Vol. 85, Issue 4, pp. 489-500, (1996) (PubMed).
-
-
- Smad1 , Smad8
-
Background
-
The N6-1233 monoclonal antibody specifically binds to the Smad1 protein phosphorylated at the Ser463/465 sites and the Smad8 protein phosphorylated at the Ser465/467 sites. Smad1 and Smad8 are ~60 kDa proteins and are members of the Smad superfamily. The Smad family members are divided into three subfamilies: receptor regulated Smads or R-Smads, including Smads1, 2, 3, 5, and 8, common partner Smad, or Co-Smad, including Smad4, and inhibitory Smads, or I-Smad, including Smads 6 and 7. Activation of Transforming Growth Factor-beta (TGF-beta) superfamily serine/threonine kinase receptors, such as TGF-beta and Bone Morphogenic Protein (BMP) receptors, leads to the phosphorylation of R-Smads at several sites. It has been shown that Ser463 and Ser465 of Smad1 are phosphorylated by BMP receptors. In B cells and pre-B cells, BMP-6 has been shown to induce Smad1/5/8 phosphorylation and inhibit cell proliferation. Phosphorylated R-Smads form complexes with Co-Smad and translocate into the nucleus to regulate transcription affecting a wide range of critical processes including cell-fate determination, proliferation, morphogenesis, differentiation and apoptosis. The inhibitory Smads inhibit this pathway through two potential mechanisms: either by preventing R-Smads from binding to their corresponding receptors and/or by competing with Smad4, the Co-Smad, from binding to R-Smads. This antibody may crossreact with Smad5 pS463/pS465 based on sequence homology.
Synonyms: Smad1,Smad8/Smad9, MADH1, MADH9 -
Molecular Weight
- ~ 60 kDa
Target
-